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Background: Intra-arterial Injection (IAI) of illicit substances by drug abusers may result in acute
ischemia, limb loss or permanent functional deﬁcit. No prospective human studies have shown that any
speciﬁc treatment is superior to another. Thoracoscopic sympathectomy (TS) has proven efﬁcacy in
upper limb ischemia due to organic blockade. This is a pilot study to evaluate the effect of thoracoscopic
sympathectomy addition to the management protocol of recreational intra-arterial drug injection.
Patients and methods: A total of 11 victims of upper limb IAI of recreational drug were recruited (10
males) with age range from 18 to 43 years old (average 30 8.3 years). Tissue Ischemia Score (TIS) was
used for pretreatment assessment of the degree of ischemic injury and severity of pain was evaluated
pre- and post-operatively using visual analog score (VAS) and compared using Student’s t test. Pre-
operative VAS score was 6.9 1.8. All enrolled patients were treated according to the following
protocol; anticoagulation, calcium channel blocker, opiates for pain, and TS. Patients received the stated
protocol for minimum of 72 h (range 3–8 days; mean 5; average 4.7 1.5 days). Freedom of amputation
and improvement of pain scores were the study endpoints.
Results: No mortality, yet one case had bleeding secondary to anticoagulant and one case of post-operative
pneumothorax that required chest tube drainage for 24 h. No patients had wet gangrene or spreading
infection. Freedom of amputation was achieved in nine patients, 81% (7 patients had normal outcome and
other two had permanent neurological deﬁcit). Two patients (18%) had tissue necrosis with dry gangrene
and mummiﬁcation of the affected digits with eventual amputation. Postoperative VAS pain score was
2.09 1.37 (p< 0.05). Pain medications were suspended in 6 patients (54.5%), reduced in 4 (36%) and
unchanged in 1 (9%). All patients with TIS score 2 or less had a normal outcome while those with scores 3
and 4 had a variable outcome. Using regression analysis, initial TIS was signiﬁcant for outcome prediction
(p¼ 0.043) while age, arterial site, drug injected and time delay were not signiﬁcant.
Conclusion: The addition of TS was an attempt to halt the ischemic process after IAI which permitted, in
our belief, optimal symptom control with maximum tissue salvage. Because the procedure is minimally
invasive, safe, and associated with a low complication rate; it worth consideration whenever IAI is
encountered.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Recreational drug abuse represents an increasing problem over
the last two decades with estimated 13.5 million drug abuser world
wide.1 Unintentional intra-arterial injection (IAI) of illicit substances
by drug abusers may result in catastrophic complicationsmanifested
by acute severe extremity ischemia with tissue necrosis and
permanent neurological dysfunction.2 Themechanisms of injury ande), þ20 101414344 (mobile).
l Samadoni).
iates Ltd. Published by Elsevier Ltopportunities for treatment are different for IAI occurring in
a hospital and that resulting from substance abuse. Iatrogenic IAI
frequently involves a single drug with no impurities, is usually
diagnosed immediately, and treatment may be initiated before the
vascular injury has fully developed.3
In contrast, IAI by addicts may involve multiple substances that
are invariably contaminated with impurities with frequent delay
from injection to treatment, allowing the ischemic injury to
develop.3,4 Therefore the usual excellent results reported in the
prompt treatment of iatrogenic IAI may not be possible in cases of
drug abuse.3–6 The advent of ischemia has a multifactorial origin
and can be dependent on site of injection, the physicochemicald. All rights reserved.
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various pathophysiological responses come into play; direct toxic
effect of the drug producing chemical endarteritis resulting in
endothelial injury, platelet activation and associated localized
thrombosis.7,8
Since the ﬁrst report of IAI by Van Der Post in 1942,9 a variety of
therapeutic modalities have been attempted to halt the ischemic
process. However, guidelines regarding its management remain
vague.10,11 Most of the studies reported small number of patients
with inadequate follow up, that would not culminate to evidence
based recommendations regarding any treatment protocol.10–15
Palmar and axillopalmar hyperhidrosis represents the com-
monest indications for dorsal sympathectomy,16 however, vascular
insufﬁciency of the upper extremities, when revascularization is
not feasible, represents a less common indication; which induces
the release of vasomotor control and hyperactive tone of the small
arteries and arterioles, improving circulation to the skin, peripheral
extremities, and bone, allowing healing of ulcers and trophic
lesions and limiting tissue necrosis.16,17
The minimal invasiveness of thoracoscopic sympathectomy had
ledmany authors, in the past two decades, to re-examine the role of
sympathectomy in intractable hand ischemia, however, only three
reports (total of 7 patients) had reported its use in IAI sitting.18–20
This is a study to evaluate the effect of thoracoscopic sympa-
thectomy addition to the management protocol of recreational
intra-arterial drug injection.
2. Materials and methods
After obtaining the approval of Department of surgery’s ethical
committee on October 2005 victims of upper limb intra-arterial
injection (IAI) of recreational drug were recruited to study the
effect of thoracoscopic sympathectomy (TS) on their outcome,
during the period from January 2006 toMay 2009 at Cairo University
Hospitals. Exclusion criteria included evidence of infective endo-
carditis, previous IAI at the same limb in question, American Society
of Anesthesiology (ASA) class III and those presenting late with
established tissue necrosis (dry gangrene). The nature of the
procedure and the potential merits as a method under study was
explained to each patient and a written informed consent was
obtained.
A total of 11 patients (10 males and one female) with age range
from 18 to 43 years old (average 30 8.3 years) were recruited
(Table 1). Heroin was the most injected substance (63.4%), while
radial artery was the most frequently injected site (5 patients). All
patients gave a history of intense unrelenting pain immediately
following injection with variable degrees of persistent pain after-
wards. Their main presentations were pain, numbness, swelling,
coldness and weakness. On examination all extremities showedTable 1
Patients’ demographics, presentations and outcome.
No. Age Sex Drug Artery Time
delay
Wrist pulse
deﬁcit
Motor
deﬁcit
Cyanosis C
1 42 M Tr Brach. 24   þ 
2 39 M Roh Brach. 36   þ þ
3 18 M Her Rad 36   þ þ
4 22 M Her Rad 24  þ  þ
5 20 M Her Ulnar 16 þ þ þ þ
6 25 M Her Brach 40  þ þ þ
7 31 M Roh Rad 18    þ
8 40 M Her Rad 24  þ þ þ
9 29 M Her Ulnar 24   þ þ
10 28 F Tr Brach 32   þ þ
11 36 M Her Rad 16    þ
Hr¼ heroin, Rop¼ rohypnol (Flunitrazepam), Tr¼ tramadol, Brach¼ brachial, Rad¼ radtemperature loss and swelling distal to the injection site. Abnormal
coolness or cold extremity was observed in 10 (90%) while cyanosis
in 8 (72%). Seven patient (64%) had sensory deﬁcit and 4 (36%) had
motor deﬁcit. Capillary reﬁll was delayed >3 s in 5 patients (45%).
All patients had normal or even accentuated pulses at the wrist
except one patient with ulnar artery injection had lost his ulnar
pulse.
Tissue Ischemia Score (TIS) devised by Treiman et al., in 199021
was used for pretreatment assessment of the degree of ischemic
injury. It reﬂects ﬁnding on initial physical examination that are
most indicative of ischemic injury. It measures four parameters
(cyanosis, coldness, delayed capillary reﬁlling and neurological
deﬁcit) and it scores 0 for its absence and 1 for its presence. The
sum of the values equal the TIS, therefore, it ranges from 0 (normal)
and 4 (severe injury). Severity of pain was evaluated pre-and post-
operatively using visual analog score (VAS), a numeric rating scale
from 0 to 10 (0¼ no pain; 1–3¼mild to moderate pain;
4–7¼ severe pain and >8 agonizing pain) and compared using
Student’s t test. Pre-operative VAS score, expressed as mean -
 standard deviation, was 6.91.8.
All enrolled patients were treated according to the following
protocol: (1) systemic anticoagulation (Enoxparine at 1 mg/kg
every 12 h SQ) after initial dose of IV sodium heparin at 80 IU/kg;
(2) calcium channel blocker (Verapamil 80 mg PO, TID); (3) opiates
for pain control; (4) adequate hydrationwith intravenous ﬂuids and
(5) thoracoscopic sympathectomy on next morning list basis. The
affected extremity was elevated, and early physiotherapy was
initiated with active and passive range of motions. Broad spectrum
antibiotics were added in case of suspected or overt infection.
Thoracoscopic sympathectomy was performed by dual port,
posterior approach technique,22,23 under general anesthesia using
single lumen tracheal intubation in prone positionwith sternal and
pelvic support. After manual induction of pneumothorax, a 10 mm
visual port was inserted at the 5th intercostal space at posterior
axillary line and another 5 mm working port at 4th intercostal
space 5–7 cm medial to the visual port with CO2 inﬂation pressure
of 5–7 mmHg. Dorsal sympathetic chain from T2 to T4 was excised
by electrocautery hook on the affected side. At the end of the
procedure the lung on the operative side was allowed to inﬂate by
the help of Valsalva’s like maneuver performed by the anesthetist
and lung expansionwas visually inspected with no need for routine
chest tube drainage. All sympathectomy procedures went
uneventfully except one case required chest tube drainage 6 h post-
operatively and was removed 24 h later.
Indications for hand and/or forearm fasciotomy were excessive
swelling not responding to proper limb elevation, tense compart-
mental boundaries and pain on passive movement of the compart-
ment’s muscles. None of our patients required fasciotomy in their
management.oldness Delayed
capillary
reﬁll
Sensory
deﬁcit
TIS Outcome Time to
outcome (d)
  1 Nr 3
 þ 3 Nr 5
þ þ 4 ND 4
þ þ 3 Nr 5
þ þ 4 TL 6
 þ 3 Nr 5
  1 Nr 3
þ 3 ND 6
þ þ 4 TL 8
  2 Nr 3
þ  2 Nr 4
ial, Nr¼ normal, ND¼ neurological deﬁcit, and TL¼ tissue loss.
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(range 3–8 days; mean 5; average 4.71.5 days). Freedom of
amputation and improvement of pain scores were the study
endpoints, freedom of amputation included patients with complete
resolution of symptoms with a normal extremity and those with
stable functional neurological deﬁcit with intact extremity.3. Results
No mortality occurred in the study, yet one patient with ulcer
history had upper GI bleeding secondary to anticoagulant, which
responded to medical management and another patient of post-
operative pneumothorax that required chest tube drainage for 24 h
with no further morbidity. No Horner’s syndrome or other collateral
effects were reported. No patients had wet gangrene or spreading
infection that required urgent debridement or amputation.
After treatment, freedom of amputation was achieved in nine
patients, 81% (7 patients had normal outcome and other two had
permanent neurological deﬁcit with intact extremity in the form of
hand contracture andweek grip in one case and inability to ﬂex two
ﬁngers in the other). Two patients (18%) had tissue necrosis with
dry gangrene and mummiﬁcation of the affected digits; eventually
they required amputation of their ﬁnger tips.
Post-operative VAS pain score was 2.091.37 and the improve-
ment from the preoperative values was statistically signiﬁcant
(p< 0.05). Pain medications were suspended in 6 patients (54.5%),
reduced in 4 (36%) and unchanged in 1 (9%) (Fig. 1).
All patients with TIS score 2 or less had a normal outcome while
those with scores 3 and 4 had a variable outcome. Three out of four
patients with TIS 3 had a normal outcome and only one patient had
a viable extremity yet with neurological deﬁcit. The situation was
evenworst for patients with TIS 4 where none had normal outcome
and two out of three required eventually amputation to their ﬁnger
tips due to dry gangrene and mummiﬁcation.
Using regression analysis, initial TIS was signiﬁcant for outcome
prediction (p¼ 0.043) while age, arterial site, drug injected and
time delay were not signiﬁcant.4. Discussion
Case reports and incidences of iatrogenic intra-arterial injection
(IAI) of medications have been published since the 1940s.24–26
During the past few decades, the source of the problem has shif-
ted from primarily hospitalized patients to people who abuse IV
drugs. Additionally, the number of implicated medications has
increased from a few sedatives to a much larger and diverse group
of substances.21
A variety of theories have been proposed to explain the devel-
opment of tissue necrosis from IAI; direct toxicity of the injectedDifference between VAS before and after sympathectomy
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Fig. 1. VAS score pre and post-operative.drug to the vascular endothelium,27 particulate emboli, altered pH
with crystal formation,28 increased platelet aggregation,7 throm-
boxane release,29and increased sympathetic discharge of norepi-
nephrine with vasospasm.30
Because of the incomplete understanding of the underlying
pathophysiology and the impracticality of performing case
controlled, prospective human studies, speciﬁc treatment algorithms
have not been well developed.31 Many therapeutic interventions
have been attempted with varying degrees of success. Most inter-
ventions are largely empirical, aiming to maintain perfusion distal to
the site of injury. No prospective human studies have shown that any
speciﬁc treatment is superior to another.8,31
The implementation of sympathectomy in the management of
peripheral ischemia is not a new concept.32,33 Many reports in the
literature examined the efﬁcacy of sympathectomy for treating
gangrene and ulcers due to occlusive arteriosclerosis of lower and
upper limb arteries with variable results.34,35 Thoracic sympa-
thectomy has been performed for occlusive and vasospastic small
arterial disease of upper extremity for several decades with mixed
results.32–37 Most series have found recurrence of symptoms after
an initial period of improvement, especially in patients with vaso-
spastic Raynaud’s syndrome.35 However, in a clear subset of
patients with organic blockage of the distal vasculature resulting in
terminal digital necrosis, gangrene, and signiﬁcant pain at rest, TS
has been found to be a valuable therapeutic option.36,37
Pain control, ulcer healing, and demarcation of necrosis appear
to be much more related to postsurgical correction of abnormal
arteriovenous shunting and to improved nutritional blood ﬂow to
ischemic areas than to the increase of total blood ﬂow.38 Recently,
sympathectomy was proved to increase the blood ﬂow by 66%,
decrease the exercise pressor response and increase exercise
tolerance by 150% due to its positive effect on skeletal muscles
bioenergetics.39
Development of TS hasmade sympathectomy for the upper limb
safe and minimally invasive. This has resulted in the procedure
being done widely, especially for palmar hyperhidrosis.19 A recent
meta-analysis of all published literature conﬁrms TS to be safe with
very low morbidity.40,41 In this study only one case developed
pneumothorax with no hemothorax or Horner syndrome.
Numerous reports in the literature had addressed the role of
sympathectomy in the sitting of limb ischemia, yet only three
reports had reported the use of thoracoscopic sympathectomy in
IAI among other causes of upper limb ischemia.18–20 Only seven
patients were reported collectively, in these series, with variable
results. De Giacomo et al.,18 reported three IAI patients, among 15
patients with upper limb ischemia, with more than 66% normal
extremity outcome, Modaghegh et al.,19 reported also three IAI
patients among 33 patients with full recovery in 31 patients, yet he
did not specify the results in particular to IAI while Becquemin
et al.,20 reported one case of failure of sympathectomy to halt the
progression of ﬁnger gangrene after incident of IAI. To our knowl-
edge, to date, no study has been exclusively dedicated to evaluate
the role of sympathectomy in IAI.
In this study thoracoscopic sympathectomy and medical treat-
ment provided effective pain control (10/11) with satisfactory hand
salvagability (9/11), even when amputation was necessary, it was
delayed until a clear demarcation of necrosis was obtained,
allowing the preservation of the maximal viable tissue. TIS proved
to be a valuable prognostic tool with good prediction to outcome.
5. Conclusion
Because of the infrequent occurrence IAI, it is unlikely that any
single institution will encounter enough patients to be able to
randomize therapies and incorporate adequate controls to prove
A. El Samadoni et al. / International Journal of Surgery 8 (2010) 229–232232conclusively superiority of a given treatment protocol. However,
the addition of TS was an attempt to halt the ischemic process after
IAI which permitted, in our belief, optimal symptom control with
maximum tissue salvage. Because the procedure is minimally
invasive, safe, and associated with a low complication rate; it worth
consideration whenever IAI is encountered.
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